<DOC>
	<DOC>NCT01076491</DOC>
	<brief_summary>This study is to investigate the safety and tolerability of high doses of inhaled mannitol in subjects with bronchiectasis to further direct development of an improved drug delivery system.</brief_summary>
	<brief_title>High Dose Inhaled Mannitol Study</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>adult subjects with nonCF bronchiectasis FEV1 &gt; 50 % predicted and &gt; 1.0L bronchiectasis due to CF or endobronchial lesion respiratory infection requiring IV antibiotics in last 4 weeks pregnancy significant haemoptysis in last 6 months active TB end stage ILD contraindications as determined by investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>